Home / Inspections / 1220609

FDA Inspection 1220609 — Biomat USA, Inc

Biomat USA, Inc — FEI 3007198312

The FDA completed an inspection of Biomat USA, Inc on October 13, 2023 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cincinnati, OH (United States)

Facility

Other inspections at this facility

  • 1118061 (VAI Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1018966 (NAI Thu Jul 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 938657 (NAI Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 849952 (NAI Wed Sep 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 721933 (NAI Thu May 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources